Aspirin and aspirin resistance in coronary artery disease

Current Opinion in Pharmacology

Volumn 13, Issue 2, 2013, Pages 242-250

  Kasmeridis, Charalampos ^a   Apostolakis, Stavros ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PRASUGREL; PROTON PUMP INHIBITOR; THROMBOXANE; TICAGRELOR;

ARACHIDONIC ACID METABOLISM; ASPIRIN RESISTANCE; BLEEDING; BRAIN HEMORRHAGE; CORONARY ARTERY DISEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG RESISTANCE; ENTERIC COATED TABLET; FLOW CYTOMETRY; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MONOTHERAPY; PATIENT COMPLIANCE; PHARMACODYNAMICS; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOELASTOGRAPHY; THROMBOSIS;

ASPIRIN; CORONARY ARTERY DISEASE; DRUG RESISTANCE; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 84879418895     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.12.004     Document Type: Review

References (43)

1. C. Patrono Aspirin resistance: definition, mechanisms and clinical read-outs J Thromb Haemost 1 2003 1710 1713
2. P.J. Mason, A.K. Jacobs, and J.E. Freedman Aspirin resistance and atherothrombotic disease J Am Coll Cardiol 46 2005 986 993 (Pubitemid 41316504)
3. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
4. W. Kuliczkowski, A. Witkowski, L. Polonski, C. Watala, K. Filipiak, A. Budaj, J. Golanski, D. Sitkiewicz, J. Pregowski, and J. Gorski Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 30 2009 426 435
5. F.M. Pulcinelli, and S. Riondino More on aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm J Thromb Haemost 4 2006 485 487
6. E. Shantsila, T. Watson, and G.Y. Lip Aspirin resistance: what, why and when? Thromb Res 119 2007 551 554
7. J. Mehta, P. Mehta, C. Burger, and C.J. Pepine Platelet aggregation studies in coronary artery disease. Past 4. Effect of aspirin Atherosclerosis 31 1978 169 175 (Pubitemid 9042840)
8. B. Rocca, P. Secchiero, G. Ciabattoni, F.O. Ranelletti, L. Catani, L. Guidotti, E. Melloni, N. Maggiano, G. Zauli, and C. Patrono Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets Proc Natl Acad Sci USA 99 2002 7634 7639 (Pubitemid 34568743)
9. G. Davì, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
10. G. Anfossi, and M. Trovati Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy Cardiovasc Hematol Agents Med Chem 4 2006 111 128 (Pubitemid 43805195)
11. G. Davi, P. Alessandrini, A. Mezzetti, G. Minotti, T. Bucciarelli, F. Costantini, F. Cipollone, G.B. Bon, G. Ciabattoni, and C. Patrono In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia Arterioscler Thromb Vasc Biol 17 1997 3230 3235 (Pubitemid 28016082)
12. M. Reilly, N. Delanty, J.A. Lawson, and G.A. FitzGerald Modulation of oxidant stress in vivo in chronic cigarette smokers Circulation 94 1996 19 25 (Pubitemid 126426395)
13. I. Chung, and G.Y. Lip Platelets and heart failure Eur Heart J 27 2006 2623 2631 (Pubitemid 44729859)
14. C.J. O'Donnell, M.G. Larson, D. Feng, P.A. Sutherland, K. Lindpaintner, R.H. Myers, R.A. D'Agostino, D. Levy, and G.H. Tofler Framingham Heart Study. Genetic and environmental contributions to platelet aggregation: the Framingham heart study Circulation 103 2001 3051 3056 (Pubitemid 32587850)
15. B. Pamukcu, H. Oflaz, and Y. Nisanci The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis Am Heart J 149 2005 675 680
16. J.A. Cambria-Kiely, and P.J. Gandhi Aspirin resistance and genetic polymorphisms J Thromb Thrombolysis 14 2002 51 58 (Pubitemid 36277691)
17. F. Catella-Lawson, M.P. Reilly, S.C. Kapoor, A.J. Cucchiara, S. DeMarco, B. Tournier, S.N. Vyas, and G.A. FitzGerald Cyclooxygenase inhibitors and the antiplatelet effects of aspirin N Engl J Med 345 2001 1809 1817
18. C. Patrono, L.A. García Rodríguez, R. Landolfi, and C. Baigent Low-dose aspirin for the prevention of atherothrombosis N Engl J Med 353 2005 2373 2383 (Pubitemid 41713749)
19. A.O. Maree, R.J. Curtin, M. Dooley, R.M. Conroy, P. Crean, D. Cox, and D.J. Fitzgerald Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease J Am Coll Cardiol 46 2005 1258 1263 (Pubitemid 41615546)
20. D. Cox, A.O. Maree, M. Dooley, R. Conroy, M.F. Byrne, and D.J. Fitzgerald Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers Stroke 37 2006 2153 2158 (Pubitemid 44309919)
21. A.Y. Gasparyan, T. Watson, and G.Y. Lip The role of aspirin in cardiovascular prevention: implications of aspirin resistance J Am Coll Cardiol 51 2008 1829 1843 (Pubitemid 351615246)
22. E. Shantsila, and G.Y. Lip 'Aspirin resistance' or treatment non-compliance: which is to blame for cardiovascular complications? J Transl Med 6 2008 47
23. M. Lotrionte, and G.G. Biondi-Zoccai The hazards of discontinuing acetylsalicylic acid therapy in those at risk of coronary artery disease Curr Opin Cardiol 23 2008 487 493
24. G.G. Biondi-Zoccai, M. Lotrionte, P. Agostoni, A. Abbate, M. Fusaro, F. Burzotta, L. Testa, I. Sheiban, and G. Sangiorgi A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease Eur Heart J 27 2006 2667 2674 (Pubitemid 44729867)
25. N.S. Nicholson, S.G. Panzer-Knodle, N.F. Haas, B.B. Taite, J.A. Szalony, J.D. Page, L.P. Feigen, D.M. Lansky, and A.K. Salyers Assessment of platelet function assays Am Heart J 135 1998 170 178
26. G. Krasopoulos, S.J. Brister, W.S. Beattie, and M.R. Buchanan Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis BMJ 336 2008 195 198 (Pubitemid 351212675)
27. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, and E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965 (Pubitemid 36315537)
28. B. Pamukcu, H. Oflaz, I. Onur, A. Oncul, M. Ozcan, B. Umman, F. Mercanoglu, M. Meric, and Y. Nisanci Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR) Blood Coagul Fibrinolysis 18 2007 187 192 (Pubitemid 46232841)
29. L. Christiaens, S. Ragot, J. Mergy, J. Allal, and L. Macchi Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study Blood Coagul Fibrinolysis 19 2008 235 239 (Pubitemid 351498729)
30. W.H. Chen, P.Y. Lee, W. Ng, H.F. Tse, and C.P. Lau Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J Am Coll Cardiol 43 2004 1122 1126 (Pubitemid 38353000)
31. G. Barone-Rochette, O. Ormezzano, B. Polack, G. Vanzetto, B. Bertrand, and J. Machecourt Resistance to platelet antiaggregants: an important cause of very late thrombosis of drug eluting stents? Observations from five cases Arch Cardiovasc Dis 101 2008 100 107 (Pubitemid 351467538)
32. B. Pamukcu, H. Oflaz, A. Oncul, B. Umman, F. Mercanoglu, M. Ozcan, M. Meric, and Y. Nisanci The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events J Thromb Thrombolysis 22 2006 103 110 (Pubitemid 44473559)
33. S. Guha, S. Mookerjee, P. Guha, P. Sardar, S. Deb, P.D. Roy, R. Karmakar, S. Mani, M.B. Hema, and S. Pyne Antiplatelet drug resistance in patients with recurrent acute coronary syndrome undergoing conservative management Indian Heart J 61 2009 348 352
34. R.S. Poston, J. Gu, J.M. Brown, J.S. Gammie, C. White, L. Nie, R.N. Pierson 3rd, and B.P. Griffith Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting J Thorac Cardiovasc Surg 131 2006 122 130 (Pubitemid 43049792)
35. M.B. Yilmaz, Y. Balbay, V. Caldir, S. Ayaz, Y. Guray, U. Guray, and S. Korkmaz Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance Thromb Res 115 2005 25 29 (Pubitemid 39572751)
36. Z.M. Chen, L.X. Jiang, Y.P. Chen, J.X. Xie, H.C. Pan, R. Peto, R. Collins, and L.S. Liu COMMIT (ClOpidogrel and Metoprolol in yocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1607 1621
37. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd, E.T. Fry, A. DeLago, C. Wilmer, E.J. Topol, and CREDO Investigators. Clopidogrel for the Reduction of Events During Observation Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
38. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox, and Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
39. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, M.K. Natarajan, K. Malmberg, H. Rupprecht, F. Zhao, and S. Chrolavicius Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
40. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. López-Sendón, G. Montalescot, P. Theroux, M.J. Claeys, F. Cools, K.A. Hill, and A.M. Skene Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189 (Pubitemid 40397259)
41. D.L. Bhatt, M.D. Flather, W. Hacke, P.B. Berger, H.R. Black, W.E. Boden, P. Cacoub, E.A. Cohen, M.A. Creager, and J.D. Easton Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial J Am Coll Cardiol 49 2007 1982 1988 (Pubitemid 46694290)
42. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
43. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, and H. Katus Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057